Investigating patients’ preferences for new anti-diabetic drugs to inform public health insurance coverage decisions: A discrete choice experiment in China

Diabetes is a major public health concern with a considerable impact on healthcare expenditures. Deciding on health insurance coverage for new drugs that meet patient needs is a challenge facing policymakers. Our study aimed to assess patients’ preferences for public health insurance coverage of new anti-diabetic drugs in China.